GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,600,000 | -75.7% | 25,813 | -87.1% | 0.00% | -72.7% |
| Q4 2020 | $23,063,000 | +12.4% | 199,842 | -5.2% | 0.01% | -15.4% |
| Q3 2020 | $20,518,000 | +69.0% | 210,760 | +113.1% | 0.01% | +44.4% |
| Q2 2020 | $12,138,000 | +132.2% | 98,905 | +65.7% | 0.01% | +80.0% |
| Q1 2020 | $5,227,000 | -75.9% | 59,701 | -71.2% | 0.01% | -83.3% |
| Q4 2019 | $21,668,000 | +255.6% | 207,236 | +291.2% | 0.03% | +200.0% |
| Q3 2019 | $6,093,000 | +10.4% | 52,970 | +65.5% | 0.01% | 0.0% |
| Q2 2019 | $5,517,000 | +30.6% | 32,000 | +27.7% | 0.01% | +42.9% |
| Q1 2019 | $4,224,000 | +219.0% | 25,059 | +84.3% | 0.01% | +133.3% |
| Q4 2018 | $1,324,000 | -85.0% | 13,599 | -73.5% | 0.00% | -83.3% |
| Q3 2018 | $8,856,000 | +86.8% | 51,267 | +50.9% | 0.02% | +63.6% |
| Q2 2018 | $4,740,000 | +218.1% | 33,968 | +157.0% | 0.01% | +175.0% |
| Q1 2018 | $1,490,000 | -83.3% | 13,215 | -80.5% | 0.00% | -84.6% |
| Q4 2017 | $8,934,000 | +310.4% | 67,676 | +215.5% | 0.03% | +271.4% |
| Q3 2017 | $2,177,000 | +2.8% | 21,450 | +1.6% | 0.01% | 0.0% |
| Q2 2017 | $2,117,000 | -62.3% | 21,118 | -54.6% | 0.01% | -72.0% |
| Q1 2017 | $5,620,000 | -64.9% | 46,469 | -67.5% | 0.02% | -63.8% |
| Q4 2016 | $15,989,000 | -58.9% | 143,077 | -51.2% | 0.07% | -62.9% |
| Q3 2016 | $38,916,000 | +681.1% | 293,200 | +439.0% | 0.19% | +644.0% |
| Q2 2016 | $4,982,000 | -40.9% | 54,400 | -53.4% | 0.02% | -46.8% |
| Q1 2016 | $8,425,000 | +1854.8% | 116,772 | +1783.4% | 0.05% | +1466.7% |
| Q4 2015 | $431,000 | -49.7% | 6,200 | -11.1% | 0.00% | -50.0% |
| Q2 2015 | $857,000 | +2.8% | 6,975 | -23.4% | 0.01% | 0.0% |
| Q1 2015 | $834,000 | -82.0% | 9,100 | -83.4% | 0.01% | -87.2% |
| Q3 2014 | $4,635,000 | -52.4% | 54,676 | -41.2% | 0.05% | -62.1% |
| Q2 2014 | $9,733,000 | +2713.0% | 92,969 | +1393.2% | 0.12% | +3000.0% |
| Q1 2014 | $346,000 | – | 6,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |